Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome

Infection
Jun Feng, Xue-Feng Sun

Abstract

Little is known about risk factors for the outcome of pulmonary mucormycosis. We summarized characteristics of this rare disease, and systemically explored risk factors for the outcome. Ninety-two patients with pulmonary mucormycosis, including 12 patients at Peking Union Medical College Hospital and 80 patients published in 62 articles between 2006 and 2016, were retrospectively analyzed. The median age was 47.5 years, and the male to female ratio was 2.8:1. Hematological disorders, diabetes mellitus, renal insufficiency and organ transplantation were main underlying conditions. Twelve percent of patients had no underlying diseases. A predilection for involvement of upper lobes was noted, and thick-walled cavity was described in 37.0% of patients on chest computed tomography. Most of the patients were diagnosed by microscopic analysis (95.7%), mainly histopathology; and only a minority were diagnosed by culture of sterile materials (28.3%). The overall mortality rate was 30.4%. Four independent determinants were associated with a better prognosis: hemoptysis (adjusted OR 7.910; 95% CI 1.411-44.342), chronic onset (adjusted OR 25.269, 95% CI 1.654-385.993), treated with medicine (adjusted OR 53.896, 95% CI 3.072-945.561), and t...Continue Reading

References

Sep 1, 1995·Journal of Computer Assisted Tomography·D A JamadarB H Gross
Apr 1, 1994·The Annals of Thoracic Surgery·M TedderJ E Lowe
Jul 1, 1995·Mycoses·B KoszycaR W Byard
Jul 1, 1999·Archives of Internal Medicine·F Y LeeK A Adal
Feb 7, 2001·Clinical Microbiology Reviews·J A RibesD J Baker
Dec 29, 2004·The Annals of Thoracic Surgery·Nick Dobrilovic, Michael A Wait
Jul 16, 2005·Clinical Microbiology Reviews·Brad SpellbergAshraf Ibrahim
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maureen M RodenThomas J Walsh
Dec 28, 2005·European Journal of Internal Medicine·Ritesh AgarwalD Gupta
Jan 25, 2006·Asian Cardiovascular & Thoracic Annals·Christophoros KotoulasGeorgios Laoutidis
Jun 7, 2006·Pathology·Kenneth OpeskinHarshal Nandurkar
Jun 27, 2006·The Annals of Thoracic Surgery·Subroto PaulYolonda L Colson
Jul 13, 2006·Cardiovascular and Interventional Radiology·Nikolaos EconomopoulosElias N Brountzos
Sep 21, 2006·Infectious Disease Clinics of North America·Dimitrios P Kontoyiannis, Russell E Lewis
Jan 11, 2007·American Journal of Clinical Pathology·Dimitrios P KontoyiannisJeffrey J Tarrand
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Volker RickertsRalf Bialek
May 5, 2007·Journal of Medical Case Reports·Tejal PatelDaniel G Peckham
Mar 15, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Nobuyuki KoyamaMinoru Kanazawa
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hisham WahbaEdith M Marom
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 8, 2008·Indian Journal of Pathology & Microbiology·Vijaya V Mysorekar, Saraswati G Rao
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Mar 6, 2009·Pathology International·Masatomo Kimura, Hiroyuki Ito
Jan 21, 2010·Antimicrobial Agents and Chemotherapy·Brad MoriyamaThomas J Walsh
Jul 1, 2008·Lung India : Official Organ of Indian Chest Society·Rajiv GargRajendra Prasad
Mar 5, 2010·Journal of Clinical Microbiology·Arunaloke ChakrabartiArvind A Padhye
Mar 26, 2010·Thorax·Chiramel George KoshyThomas Mammen
May 13, 2010·Clinical and Experimental Nephrology·Gaku KusabaYasuhiko Tomino
Jul 27, 2010·Radiology·Jonathan H ChungSudhakar J Pipavath
Jun 10, 2011·Lung India : Official Organ of Indian Chest Society·Sundaram ChallaManmadha T Rao
Sep 3, 2011·The European Respiratory Journal·H-C LiuM-C Lu
Dec 15, 2011·Seminars in Respiratory and Critical Care Medicine·Georgios HamilosDimitrios P Kontoyiannis
Jan 25, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George PetrikkosDimitrios P Kontoyiannis
Jan 25, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshDimitrios P Kontoyiannis
Mar 1, 2012·Respiratory Care·Jesse Theisen-ToupalDavid H Roberts
Jul 13, 2012·Clinical Nuclear Medicine·Chun-Jiang DangXiao-Ming Shang
Aug 25, 2012·Critical Reviews in Microbiology·Joerg J VehreschildOliver A Cornely
Oct 19, 2012·Transplant Infectious Disease : an Official Journal of the Transplantation Society·D SchneidawindW Bethge

❮ Previous
Next ❯

Citations

Apr 19, 2020·Mycoses·Hyo-Ju SonSung-Han Kim
Mar 25, 2019·Journal of Fungi·Hariprasath Prakash, Arunaloke Chakrabarti
Jul 28, 2019·Journal of Fungi·Kathleen P HartnettKarlyn D Beer
Dec 1, 2020·The Journal of International Medical Research·Weipeng ShaoDeruo Liu
Jan 9, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Valliappan MuthuArunaloke Chakrabarti
Apr 4, 2021·Microorganisms·Hariprasath Prakash, Arunaloke Chakrabarti
Sep 8, 2020·Chest·Cihan PapanSören L Becker
May 22, 2021·Infectious Disease Clinics of North America·Julie M Steinbrink, Marisa H Miceli
Jul 15, 2021·Lung India : Official Organ of Indian Chest Society·Mohan Venkatesh PulleArvind Kumar
Jul 30, 2021·International Journal of Biological Macromolecules·Anamika SinghPradeep Sharma
Sep 12, 2019·Respiration; International Review of Thoracic Diseases·Faguang JinHaitao Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.